Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 3:03 pm Sale | 2023-12-31 | 13G | Korro Bio, Inc. KRRO | Cormorant Asset Management, LP | 529,170 6.610% | -150,000 (-22.09%) | Filing History |
| 2024-02-14 3:03 pm Purchase | 2023-12-31 | 13G | Ambrx Biopharma Inc. AMAM | Cormorant Asset Management, LP | 11,231,000 17.780% | 11,231,000 (New Position) | Filing History |
| 2024-02-14 3:02 pm Sale | 2023-12-31 | 13G | Monte Rosa Therapeutics, Inc. GLUE | Cormorant Asset Management, LP | 0 0.000% | -2,893,717 (Position Closed) | Filing History |
| 2024-02-14 3:02 pm Sale | 2023-12-31 | 13G | Elevation Oncology, Inc. ELEV | Cormorant Asset Management, LP | 0 0.000% | -1,952,032 (Position Closed) | Filing History |
| 2024-02-14 3:01 pm Unchanged | 2023-12-31 | 13G | Eledon Pharmaceuticals, Inc. ELDN | Cormorant Asset Management, LP | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-02-14 3:01 pm Sale | 2023-12-31 | 13G | Constellation Pharmaceuticals, Inc. CNST | Cormorant Asset Management, LP | 0 0.000% | -5,150,000 (Position Closed) | Filing History |
| 2024-02-14 3:01 pm Sale | 2023-12-31 | 13G | Cabaletta Bio, Inc. CABA | Cormorant Asset Management, LP | 0 0.000% | -1,971,739 (Position Closed) | Filing History |
| 2024-02-14 3:00 pm Sale | 2023-12-31 | 13G | Astria Therapeutics, Inc. ATXS | Cormorant Asset Management, LP | 0 0.000% | -1,650,000 (Position Closed) | Filing History |
| 2024-02-14 3:00 pm Sale | 2023-12-19 | 13G | 89bio, Inc. ETNB | Cormorant Asset Management, LP | 0 0.000% | -2,550,000 (Position Closed) | Filing History |
| 2024-01-30 4:41 pm Sale | 2023-11-29 | 13D | Erasca, Inc. ERAS | Cormorant Asset Management, LP | 0 0.000% | -10,893,107 (Position Closed) | Filing History |
| 2023-12-14 4:04 pm Purchase | 2023-12-04 | 13G | EyePoint Pharmaceuticals, Inc. EYPT | Cormorant Asset Management, LP | 6,038,235 12.360% | 6,038,235 (New Position) | Filing History |
| 2023-11-16 4:02 pm Purchase | 2023-11-06 | 13G | Korro Bio, Inc. KRRO | Cormorant Asset Management, LP | 679,170 8.490% | 679,170 (New Position) | Filing History |
| 2023-11-13 4:03 pm Purchase | 2023-11-01 | 13G | VYNE Therapeutics Inc. VYNE | Cormorant Asset Management, LP | 1,394,336 9.990% | 1,394,336 (New Position) | Filing History |
| 2023-11-06 4:01 pm Purchase | 2023-10-25 | 13G | Harpoon Therapeutics, Inc. HARP | Cormorant Asset Management, LP | 1,678,619 9.900% | 1,678,619 (New Position) | Filing History |
| 2023-10-23 4:02 pm Purchase | 2023-10-11 | 13G | Alpine Immune Sciences, Inc. ALPN | Cormorant Asset Management, LP | 2,850,000 5.790% | 2,850,000 (New Position) | Filing History |
| 2023-10-13 4:00 pm Purchase | 2023-10-03 | 13G | ALX Oncology Holdings Inc. ALXO | Cormorant Asset Management, LP | 3,142,079 6.310% | 3,142,079 (New Position) | Filing History |
| 2023-10-10 4:01 pm Purchase | 2023-09-29 | 13G | Marinus Pharmaceuticals, Inc. MRNS | Cormorant Asset Management, LP | 2,800,000 5.530% | 2,800,000 (New Position) | Filing History |
| 2023-04-24 5:26 pm Purchase | 2023-04-20 | 13G | Immuneering Corporation IMRX | Cormorant Asset Management, LP | 4,204,364 14.420% | 1,918,183 (+83.90%) | Filing History |
| 2023-03-13 4:00 pm Purchase | 2023-03-03 | 13G | Ambrx Biopharma Inc. AMAM | Cormorant Asset Management, LP | 52,500,000 17.730% | 36,145,298 (+221.01%) | Filing History |
| 2023-02-14 3:15 pm Sale | 2022-12-31 | 13G | Elevation Oncology, Inc. ELEV | Cormorant Asset Management, LP | 1,952,032 8.380% | -31,136 (-1.57%) | Filing History |